Timber Pharmaceuticals Inc Stock News

Timber (TMBR) surges as LEO Pharma offers to acquire it for approximately $36 million.

Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. According to a press release from Timber Pharm

Timber (TMBR) receives a dermal carcinogenicity waiver from the FDA for TMB-001, which is being developed to treat moderate-to-severe subtypes of congenital ichthyosis.

Timber Pharmaceuticals, Inc. (TMBR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong a

Use these tips for buying penny stocks for the long term The post Building a Penny Stocks Portfolio For Long Term  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com

Use these tips to analyze penny stocks The post Penny Stock Investing: How to Analyze Market Conditions appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is taking off on Friday after getting an orphan drug designation in Europe. That comes from the EC and covers TMB-001 for the treatment of X-linked reces

Penny stocks under $1 to watch this week. The post Top Penny Stocks To Buy?

Here's what you need to know about trading penny stocks on August 10th The post Best Penny Stocks to Buy Now? 3 For Your August List appeared first on Penny Stocks to Buy, Picks, News and Information

Are these under $1 penny stocks on your watchlist? The post Best Penny Stocks to Buy Under $1?

Timber Pharmaceuticals Inc (TMBR) shares closed today at 1.4% above its 52 week low of $0.33, giving the company a market cap of $21M. The stock is currently down 12.4% year-to-date, down 69.2% over the past 12 months, and down 96.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 49.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1958.1% The company's stock price performance over the past 12 months lags the peer average by 329.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Timber Pharmaceuticals Inc (TMBR) shares closed 7.0% lower than its previous 52 week low, giving the company a market cap of $23M. The stock is currently down 4.9% year-to-date, down 69.1% over the past 12 months, and down 96.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 45.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1947.2% The company's stock price performance over the past 12 months lags the peer average by 336.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Virtual Conference on January 10-13, 2022

Call to be held on Monday, November 22nd at 10:00am ET

The stock price of Timber Pharmaceuticals Inc (NYSEAMERICAN: TMBR) fell by over 33% during intraday trading today. This is why it happened.